230 related articles for article (PubMed ID: 17511615)
1. The brain galanin receptors: targets for novel antidepressant drugs.
Lu X; Sharkey L; Bartfai T
CNS Neurol Disord Drug Targets; 2007 Jun; 6(3):183-92. PubMed ID: 17511615
[TBL] [Abstract][Full Text] [Related]
2. Galanin receptor antagonists : a potential novel pharmacological treatment for mood disorders.
Ogren SO; Kuteeva E; Hökfelt T; Kehr J
CNS Drugs; 2006; 20(8):633-54. PubMed ID: 16863269
[TBL] [Abstract][Full Text] [Related]
3. Influence of chronic administration of antidepressant drugs on mRNA for galanin, galanin receptors, and tyrosine hydroxylase in catecholaminergic and serotonergic cell-body regions in rat brain.
Rovin ML; Boss-Williams KA; Alisch RS; Ritchie JC; Weinshenker D; West CH; Weiss JM
Neuropeptides; 2012 Apr; 46(2):81-91. PubMed ID: 22317959
[TBL] [Abstract][Full Text] [Related]
4. Galanin, galanin receptor subtypes and depression-like behaviour.
Kuteeva E; Hökfelt T; Wardi T; Ogren SO
Exp Suppl; 2010; 102():163-81. PubMed ID: 21299068
[TBL] [Abstract][Full Text] [Related]
5. Galanin, galanin receptor subtypes and depression-like behaviour.
Kuteeva E; Hökfelt T; Wardi T; Ogren SO
Cell Mol Life Sci; 2008 Jun; 65(12):1854-63. PubMed ID: 18500640
[TBL] [Abstract][Full Text] [Related]
6. Chronic venlafaxine treatment fails to alter the levels of galanin system transcripts in normal rats.
Petschner P; Juhasz G; Tamasi V; Adori C; Tothfalusi L; Hökfelt T; Bagdy G
Neuropeptides; 2016 Jun; 57():65-70. PubMed ID: 26891823
[TBL] [Abstract][Full Text] [Related]
7. A role for galanin in antidepressant actions with a focus on the dorsal raphe nucleus.
Lu X; Barr AM; Kinney JW; Sanna P; Conti B; Behrens MM; Bartfai T
Proc Natl Acad Sci U S A; 2005 Jan; 102(3):874-9. PubMed ID: 15647369
[TBL] [Abstract][Full Text] [Related]
8. Galanin, galanin receptors, and drug targets.
Mitsukawa K; Lu X; Bartfai T
Exp Suppl; 2010; 102():7-23. PubMed ID: 21299058
[TBL] [Abstract][Full Text] [Related]
9. Monoamine neurocircuitry in depression and strategies for new treatments.
Hamon M; Blier P
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950
[TBL] [Abstract][Full Text] [Related]
10. Distribution and differential regulation of galanin receptor subtypes in rat brain: effects of seizure activity.
Lu X; Mazarati A; Sanna P; Shinmei S; Bartfai T
Neuropeptides; 2005 Jun; 39(3):147-52. PubMed ID: 15944003
[TBL] [Abstract][Full Text] [Related]
11. Galanin, galanin receptors and drug targets.
Mitsukawa K; Lu X; Bartfai T
Cell Mol Life Sci; 2008 Jun; 65(12):1796-805. PubMed ID: 18500647
[TBL] [Abstract][Full Text] [Related]
12. Distinct features of neurotransmitter systems in the human brain with focus on the galanin system in locus coeruleus and dorsal raphe.
Le Maître E; Barde SS; Palkovits M; Diaz-Heijtz R; Hökfelt TG
Proc Natl Acad Sci U S A; 2013 Feb; 110(6):E536-45. PubMed ID: 23341594
[TBL] [Abstract][Full Text] [Related]
13. Galanin contributes to monoaminergic dysfunction and to dependent neurobehavioral comorbidities of epilepsy.
Medel-Matus JS; Shin D; Sankar R; Mazarati A
Exp Neurol; 2017 Mar; 289():64-72. PubMed ID: 28013000
[TBL] [Abstract][Full Text] [Related]
14. [Domino principle--monoamines in bottom-view].
Sümegi A
Neuropsychopharmacol Hung; 2008 Jun; 10(3):131-40. PubMed ID: 18956617
[TBL] [Abstract][Full Text] [Related]
15. The galanin and galanin receptor subtypes, its regulatory role in the biological and pathological functions.
Šípková J; Kramáriková I; Hynie S; Klenerová V
Physiol Res; 2017 Nov; 66(5):729-740. PubMed ID: 28730831
[TBL] [Abstract][Full Text] [Related]
16. Galanin as a modulator of anxiety and depression and a therapeutic target for affective disease.
Karlsson RM; Holmes A
Amino Acids; 2006 Oct; 31(3):231-9. PubMed ID: 16733616
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant properties of substance P antagonists: relationship to monoaminergic mechanisms?
Adell A
Curr Drug Targets CNS Neurol Disord; 2004 Apr; 3(2):113-21. PubMed ID: 15078186
[TBL] [Abstract][Full Text] [Related]
18. Characterization of GalR1, GalR2, and GalR3 immunoreactivity in catecholaminergic nuclei of the mouse brain.
Hawes JJ; Picciotto MR
J Comp Neurol; 2004 Nov; 479(4):410-23. PubMed ID: 15514977
[TBL] [Abstract][Full Text] [Related]
19. Galanin and NPY, two peptides with multiple putative roles in the nervous system.
Hökfelt T; Broberger C; Diez M; Xu ZQ; Shi T; Kopp J; Zhang X; Holmberg K; Landry M; Koistinaho J
Horm Metab Res; 1999 May; 31(5):330-4. PubMed ID: 10422730
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic analysis of GalR2 knockout mice in anxiety- and depression-related behavioral tests.
Lu X; Ross B; Sanchez-Alavez M; Zorrilla EP; Bartfai T
Neuropeptides; 2008 Aug; 42(4):387-97. PubMed ID: 18554714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
